These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24050241)

  • 21. Argonaute-2-dependent rescue of a Drosophila model of FXTAS by FRAXE premutation repeat.
    Sofola OA; Jin P; Botas J; Nelson DL
    Hum Mol Genet; 2007 Oct; 16(19):2326-32. PubMed ID: 17635840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed myelination in a mouse model of fragile X syndrome.
    Pacey LK; Xuan IC; Guan S; Sussman D; Henkelman RM; Chen Y; Thomsen C; Hampson DR
    Hum Mol Genet; 2013 Oct; 22(19):3920-30. PubMed ID: 23740941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic modifiers in mice: the example of the fragile X mouse model.
    Errijgers V; Kooy RF
    Cytogenet Genome Res; 2004; 105(2-4):448-54. PubMed ID: 15237233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drosophila strategies to study psychiatric disorders.
    van Alphen B; van Swinderen B
    Brain Res Bull; 2013 Mar; 92():1-11. PubMed ID: 21978945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drosophila: a "model" model system to study neurodegeneration.
    Celotto AM; Palladino MJ
    Mol Interv; 2005 Oct; 5(5):292-303. PubMed ID: 16249525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental therapeutic models for fragile X syndrome].
    de Diego-Otero Y
    Rev Neurol; 2001 Oct; 33 Suppl 1():S70-6. PubMed ID: 12447824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Research progress of transgenic Drosophila model of Alzheimer disease].
    Tan Y; Ji YB; Zhao J
    Yao Xue Xue Bao; 2013 Mar; 48(3):333-6. PubMed ID: 23724643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired phagocytosis in fragile X.
    Mushegian AA
    Sci Signal; 2017 Apr; 10(473):. PubMed ID: 28377409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complex behavior of simple repeats: the fragile X syndrome.
    Oostra BA; Halley DJ
    Pediatr Res; 1995 Nov; 38(5):629-37. PubMed ID: 8552426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomedical research. A fix for fragile X syndrome?
    Miller G
    Science; 2006 Apr; 312(5773):521. PubMed ID: 16645065
    [No Abstract]   [Full Text] [Related]  

  • 31. Age-dependent cognitive impairment in a Drosophila fragile X model and its pharmacological rescue.
    Choi CH; McBride SM; Schoenfeld BP; Liebelt DA; Ferreiro D; Ferrick NJ; Hinchey P; Kollaros M; Rudominer RL; Terlizzi AM; Koenigsberg E; Wang Y; Sumida A; Nguyen HT; Bell AJ; McDonald TV; Jongens TA
    Biogerontology; 2010 Jun; 11(3):347-62. PubMed ID: 20039205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS).
    Van Dam D; Errijgers V; Kooy RF; Willemsen R; Mientjes E; Oostra BA; De Deyn PP
    Behav Brain Res; 2005 Jul; 162(2):233-9. PubMed ID: 15876460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse.
    Yan QJ; Asafo-Adjei PK; Arnold HM; Brown RE; Bauchwitz RP
    Genes Brain Behav; 2004 Dec; 3(6):337-59. PubMed ID: 15544577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic mouse model for the fragile X syndrome.
    Kooy RF; D'Hooge R; Reyniers E; Bakker CE; Nagels G; De Boulle K; Storm K; Clincke G; De Deyn PP; Oostra BA; Willems PJ
    Am J Med Genet; 1996 Aug; 64(2):241-5. PubMed ID: 8844056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent efforts to model human diseases in vivo in Drosophila.
    Pfleger CM; Reiter LT
    Fly (Austin); 2008; 2(3):129-32. PubMed ID: 18820469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug discovery through functional screening in the Drosophila heart.
    Akasaka T; Ocorr K
    Methods Mol Biol; 2009; 577():235-49. PubMed ID: 19718521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fruitful research: drug target discovery for neurodegenerative diseases in Drosophila.
    Konsolaki M
    Expert Opin Drug Discov; 2013 Dec; 8(12):1503-13. PubMed ID: 24151920
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Sarkar S; DAS A
    J Biosci; 2023; 48():. PubMed ID: 37929819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantifying and predicting Drosophila larvae crawling phenotypes.
    Günther MN; Nettesheim G; Shubeita GT
    Sci Rep; 2016 Jun; 6():27972. PubMed ID: 27323901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drosophila as a lipotoxicity model organism--more than a promise?
    Kühnlein RP
    Biochim Biophys Acta; 2010 Mar; 1801(3):215-21. PubMed ID: 19781664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.